NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $385,846 | +0.9% | 3,788 | 0.0% | 0.16% | -2.4% |
| Q2 2023 | $382,247 | +9.7% | 3,788 | 0.0% | 0.16% | 0.0% |
| Q1 2023 | $348,496 | +1.4% | 3,788 | 0.0% | 0.16% | +0.6% |
| Q4 2022 | $343,647 | +19.3% | 3,788 | 0.0% | 0.16% | +0.6% |
| Q3 2022 | $288,000 | -41.1% | 3,788 | -34.6% | 0.16% | -39.4% |
| Q2 2022 | $489,000 | -3.7% | 5,788 | 0.0% | 0.27% | +19.0% |
| Q1 2022 | $508,000 | +0.4% | 5,788 | 0.0% | 0.23% | -13.1% |
| Q4 2021 | $506,000 | -10.8% | 5,788 | -3.5% | 0.26% | -23.1% |
| Q4 2020 | $567,000 | -88.2% | 6,000 | -89.4% | 0.34% | -78.6% |
| Q1 2014 | $4,822,000 | -44.4% | 56,713 | -47.4% | 1.58% | -44.6% |
| Q4 2013 | $8,674,000 | +3.7% | 107,916 | -1.0% | 2.84% | -2.9% |
| Q3 2013 | $8,365,000 | +7.5% | 109,043 | -0.9% | 2.93% | +2.1% |
| Q2 2013 | $7,782,000 | – | 110,058 | – | 2.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |